{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:12:46Z","timestamp":1789704766243,"version":"4.0.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Swedish Heart\u2013Lung Foundation","doi-asserted-by":"publisher","award":["#20190449"],"award-info":[{"award-number":["#20190449"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart\u2013Lung Foundation","doi-asserted-by":"publisher","award":["#20200522"],"award-info":[{"award-number":["#20200522"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart\u2013Lung Foundation","doi-asserted-by":"publisher","award":["#20220383"],"award-info":[{"award-number":["#20220383"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"publisher","award":["#20220780"],"award-info":[{"award-number":["#20220780"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006189","name":"Albert P\u00e5hlsson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"publisher","award":["CVON2017-20"],"award-info":[{"award-number":["CVON2017-20"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2009-1039"],"award-info":[{"award-number":["2009-1039"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["349-2006-237"],"award-info":[{"award-number":["349-2006-237"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018-02939"],"award-info":[{"award-number":["2018-02939"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The interleukin-1 receptor accessory protein (IL1RAP) is a co-receptor required for signalling through the IL-1, IL-33, and IL-36 receptors. Using a novel anti-IL1RAP-blocking antibody, we investigated the role of IL1RAP in atherosclerosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Single-cell RNA sequencing data from human atherosclerotic plaques revealed the expression of IL1RAP and several IL1RAP-related cytokines and receptors, including IL1B and IL33. Histological analysis showed the presence of IL1RAP in both the plaque and adventitia, and flow cytometry of murine atherosclerotic aortas revealed IL1RAP expression on plaque leucocytes, including neutrophils and macrophages. High-cholesterol diet fed apolipoprotein E\u2013deficient (Apoe\u2212\/\u2212) mice were treated with a novel non-depleting IL1RAP-blocking antibody or isotype control for the last 6 weeks of diet. IL1RAP blockade in mice resulted in a 20% reduction in subvalvular plaque size and limited the accumulation of neutrophils and monocytes\/macrophages in plaques and of T cells in adventitia, compared with control mice. Indicative of reduced plaque inflammation, the expression of several genes related to leucocyte recruitment, including Cxcl1 and Cxcl2, was reduced in brachiocephalic arteries of anti-IL1RAP-treated mice, and the expression of these chemokines in human plaques was mainly restricted to CD68+ myeloid cells. Furthermore, in vitro studies demonstrated that IL-1, IL-33, and IL-36 induced CXCL1 release from both macrophages and fibroblasts, which could be mitigated by IL1RAP blockade.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Limiting IL1RAP-dependent cytokine signalling pathways in atherosclerotic mice reduces plaque burden and plaque inflammation, potentially by limiting plaque chemokine production.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvae046","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T14:00:02Z","timestamp":1712066402000},"page":"581-595","source":"Crossref","is-referenced-by-count":26,"title":["Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3352-0403","authenticated-orcid":false,"given":"Megan","family":"Mulholland","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Immune Regulation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-1952","authenticated-orcid":false,"given":"Marie A C","family":"Depuydt","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-9505","authenticated-orcid":false,"given":"Gabriel","family":"Jakobsson","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Cardiac Inflammation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Ljungcrantz","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Immune Regulation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2007-8457","authenticated-orcid":false,"given":"Andrietta","family":"Grentzmann","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Immune Regulation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"To","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Matrix and Inflammation in Atherosclerosis, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bengtsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Matrix and Inflammation in Atherosclerosis, Lund University , Malm\u00f6 , Sweden"},{"name":"Department of Biomedical Science, Malm\u00f6 University , Malm\u00f6 , Sweden"},{"name":"Biofilms\u2014Research Center for Biointerfaces, Malm\u00f6 University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1334-8642","authenticated-orcid":false,"given":"Elin","family":"Jaensson Gyllenb\u00e4ck","sequence":"additional","affiliation":[{"name":"Cantargia AB , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitr\u00edona","family":"Gr\u00f6nberg","sequence":"additional","affiliation":[{"name":"Cantargia AB , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-6456","authenticated-orcid":false,"given":"Sara","family":"Rattik","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Immune Regulation, Lund University , Malm\u00f6 , Sweden"},{"name":"Cantargia AB , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liberg","sequence":"additional","affiliation":[{"name":"Cantargia AB , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-5050","authenticated-orcid":false,"given":"Alexandru","family":"Schiopu","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Cardiac Inflammation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-0857","authenticated-orcid":false,"given":"Harry","family":"Bj\u00f6rkbacka","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Cellular Metabolism and Inflammation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-690X","authenticated-orcid":false,"given":"Johan","family":"Kuiper","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-1959","authenticated-orcid":false,"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-0503","authenticated-orcid":false,"given":"Bram","family":"Sl\u00fctter","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-5210","authenticated-orcid":false,"given":"Daniel","family":"Engelbertsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cardiovascular Research\u2014Immune Regulation, Lund University , Malm\u00f6 , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"2024050708125794200_cvae046-B1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2024050708125794200_cvae046-B2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2024050708125794200_cvae046-B3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"2024050708125794200_cvae046-B4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2024050708125794200_cvae046-B5","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/eurheartj\/ehz008","article-title":"Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis","volume":"40","author":"Vromman","year":"2019","journal-title":"Eur Heart J"},{"key":"2024050708125794200_cvae046-B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"2024050708125794200_cvae046-B7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2011.01.008","article-title":"Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1\u03b1","volume":"405","author":"Kamari","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2024050708125794200_cvae046-B8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1\u03b1 and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat Immunol"},{"key":"2024050708125794200_cvae046-B9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/iid3.62","article-title":"Atherosclerosis severity is not affected by a deficiency in IL-33\/ST2 signaling","volume":"3","author":"Martin","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"2024050708125794200_cvae046-B10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"2024050708125794200_cvae046-B11","doi-asserted-by":"crossref","first-page":"e155236","DOI":"10.1172\/jci.insight.155236","article-title":"Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischemia\/reperfusion injury in mice","volume":"7","author":"El-Awaisi","year":"2022","journal-title":"JCI Insight"},{"key":"2024050708125794200_cvae046-B12","doi-asserted-by":"crossref","first-page":"155630","DOI":"10.1016\/j.cyto.2021.155630","article-title":"Interleukin-36\u03b3 aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice","volume":"146","author":"Zhang","year":"2021","journal-title":"Cytokine"},{"key":"2024050708125794200_cvae046-B13","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1002\/jcp.29813","article-title":"Interleukin-36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome","volume":"235","author":"Tian","year":"2020","journal-title":"J Cell Physiol"},{"key":"2024050708125794200_cvae046-B14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10564-004-2304-6","article-title":"Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design","volume":"19","author":"Verhoeven","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"2024050708125794200_cvae046-B15","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ Res"},{"key":"2024050708125794200_cvae046-B16","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","article-title":"Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice","volume":"292","author":"Lo","year":"2017","journal-title":"J Biol Chem"},{"key":"2024050708125794200_cvae046-B17","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2024050708125794200_cvae046-B18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s42003-021-01703-3","article-title":"IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice","volume":"4","author":"Koss","year":"2021","journal-title":"Commun Biol"},{"key":"2024050708125794200_cvae046-B19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/cvr\/cvx196","article-title":"IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis","volume":"114","author":"Engelbertsen","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2024050708125794200_cvae046-B20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J Clin Invest"},{"key":"2024050708125794200_cvae046-B21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ncb3346","article-title":"Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal","volume":"18","author":"Pietras","year":"2016","journal-title":"Nat Cell Biol"},{"key":"2024050708125794200_cvae046-B22","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/cvr\/cvab337","article-title":"Interleukin-1\u03b2 suppression dampens inflammatory leucocyte production and uptake in atherosclerosis","volume":"118","author":"Hettwer","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024050708125794200_cvae046-B23","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.20180147","article-title":"IL1RAP potentiates multiple oncogenic signaling pathways in AML","volume":"215","author":"Mitchell","year":"2018","journal-title":"J Exp Med"},{"key":"2024050708125794200_cvae046-B24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2011.09.014","article-title":"Flt3 signaling-dependent dendritic cells protect against atherosclerosis","volume":"35","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"2024050708125794200_cvae046-B25","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2015-11-679985","article-title":"IL1RAP antibodies block IL-1\u2013induced expansion of candidate CML stem cells and mediate cell killing in xenograft models","volume":"128","author":"\u00c5gerstam","year":"2016","journal-title":"Blood"},{"key":"2024050708125794200_cvae046-B26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gut.2009.193599","article-title":"Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts","volume":"59","author":"Nishida","year":"2010","journal-title":"Gut"},{"key":"2024050708125794200_cvae046-B27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00262-022-03277-3","article-title":"Blockade of IL-1\u03b1 and IL-1\u03b2 signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy","volume":"72","author":"Rydberg Millrud","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"2024050708125794200_cvae046-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.06.002","article-title":"Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling","volume":"60","author":"Turner","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"2024050708125794200_cvae046-B29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia\u2013reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2024050708125794200_cvae046-B30","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.3390\/ijms23094906","article-title":"The anti-atherosclerosis effect of anakinra, a recombinant human interleukin-1 receptor antagonist, in apolipoprotein E knockout mice","volume":"23","author":"Ku","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024050708125794200_cvae046-B31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"2024050708125794200_cvae046-B32","doi-asserted-by":"crossref","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024050708125794200_cvae046-B33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2024050708125794200_cvae046-B34","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2024050708125794200_cvae046-B35","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2024050708125794200_cvae046-B36","doi-asserted-by":"crossref","first-page":"e0152474","DOI":"10.1371\/journal.pone.0152474","article-title":"Redundancy of IL-1 isoform signaling and its implications for arterial remodeling","volume":"11","author":"Beltrami-Moreira","year":"2016","journal-title":"PLoS One"},{"key":"2024050708125794200_cvae046-B37","doi-asserted-by":"crossref","first-page":"R272","DOI":"10.1152\/ajpregu.00435.2016","article-title":"Interleukin-33 induces growth-regulated oncogene-alpha expression and secretion in human umbilical vein endothelial cells","volume":"313","author":"Yamamoto","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024050708125794200_cvae046-B38","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","article-title":"Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice","volume":"24","author":"Gomez","year":"2018","journal-title":"Nat Med"},{"key":"2024050708125794200_cvae046-B39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024050708125794200_cvae046-B40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.17.2.310","article-title":"P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes","volume":"17","author":"Sakai","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024050708125794200_cvae046-B41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.97.1.75","article-title":"Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice","volume":"97","author":"Patel","year":"1998","journal-title":"Circulation"},{"key":"2024050708125794200_cvae046-B42","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/01.ATV.20.12.2630","article-title":"ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice ApoE-\/-ICAM-1-\/- fed a fat or a chow diet","volume":"20","author":"Bourdillon","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024050708125794200_cvae046-B43","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1152\/ajpregu.00738.2001","article-title":"Chemokines and chemokine receptors in leukocyte trafficking","volume":"283","author":"Olson","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024050708125794200_cvae046-B44","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.1700129","article-title":"CXCL1 and CXCL2 regulate NLRP3 inflammasome activation via G-protein\u2013coupled receptor CXCR2","volume":"199","author":"Boro","year":"2017","journal-title":"J Immun"},{"key":"2024050708125794200_cvae046-B45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","article-title":"Chemokines in atherosclerosis: proceedings resumed","volume":"34","author":"Zernecke","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024050708125794200_cvae046-B46","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2353\/ajpath.2006.040748","article-title":"Up-regulated expression of the CXCR2 ligand KC\/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression","volume":"168","author":"Boisvert","year":"2006","journal-title":"Am J Pathol"},{"key":"2024050708125794200_cvae046-B47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI1195","article-title":"A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice","volume":"101","author":"Boisvert","year":"1998","journal-title":"J Clin Invest"},{"key":"2024050708125794200_cvae046-B48","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI12877","article-title":"The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium","volume":"108","author":"Huo","year":"2001","journal-title":"J Clin Invest"},{"key":"2024050708125794200_cvae046-B49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cardiores.2007.06.023","article-title":"The role of the adventitia in vascular inflammation","volume":"75","author":"Maiellaro","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2024050708125794200_cvae046-B50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajpath.2019.10.021","article-title":"Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease","volume":"190","author":"Tinajero","year":"2020","journal-title":"Am J Pathol"},{"key":"2024050708125794200_cvae046-B51","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2009-11-252643","article-title":"Platelet interleukin-1\u03b1 drives cerebrovascular inflammation","volume":"115","author":"Thornton","year":"2010","journal-title":"Blood"},{"key":"2024050708125794200_cvae046-B52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-017-0175-y","article-title":"Microglia-derived IL-1\u03b2 promotes chemokine expression by M\u00fcller cells and RPE in focal retinal degeneration","volume":"12","author":"Natoli","year":"2017","journal-title":"Mol Neurodegener"},{"key":"2024050708125794200_cvae046-B53","doi-asserted-by":"crossref","first-page":"e155581","DOI":"10.1172\/jci.insight.155581","article-title":"IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD","volume":"7","author":"Baker","year":"2022","journal-title":"JCI Insight"},{"key":"2024050708125794200_cvae046-B54","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","article-title":"Targeting interleukin-1beta reduces leukocyte production after acute myocardial infarction","volume":"132","author":"Sager","year":"2015","journal-title":"Circulation"},{"key":"2024050708125794200_cvae046-B55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20080752","article-title":"Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-\/- mice","volume":"206","author":"Grabner","year":"2009","journal-title":"J Exp Med"},{"key":"2024050708125794200_cvae046-B56","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.092324399","article-title":"Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size","volume":"99","author":"Devlin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024050708125794200_cvae046-B57","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41598-018-19476-x","article-title":"IL-36\/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis","volume":"8","author":"Ahsan","year":"2018","journal-title":"Sci Rep"},{"key":"2024050708125794200_cvae046-B58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(15)00034-0","article-title":"Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis","volume":"3","author":"Interleukin 1 Genetics Consortium","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024050708125794200_cvae046-B59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med"},{"key":"2024050708125794200_cvae046-B60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J Clin Invest"},{"key":"2024050708125794200_cvae046-B61","doi-asserted-by":"crossref","first-page":"15781","DOI":"10.1038\/ncomms15781","article-title":"Type-2 innate lymphoid cells control the development of atherosclerosis in mice","volume":"8","author":"Newland","year":"2017","journal-title":"Nat Commun"},{"key":"2024050708125794200_cvae046-B62","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/ATVBAHA.115.306048","article-title":"Expansion of CD25+ innate lymphoid cells reduces atherosclerosis","volume":"35","author":"Engelbertsen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024050708125794200_cvae046-B63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jacc.2021.07.018","article-title":"Innate lymphoid cells promote recovery of ventricular function after myocardial infarction","volume":"78","author":"Yu","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024050708125794200_cvae046-B64","doi-asserted-by":"crossref","first-page":"727956","DOI":"10.3389\/fphar.2021.727956","article-title":"The role of IL-36 in the pathophysiological processes of autoimmune diseases","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"2024050708125794200_cvae046-B65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024050708125794200_cvae046-B66","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.118.11157","article-title":"IL-33 (interleukin 33)\/sST2 axis in hypertension and heart failure","volume":"72","author":"Ghali","year":"2018","journal-title":"Hypertension"},{"key":"2024050708125794200_cvae046-B67","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41416-021-01657-7","article-title":"First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours","volume":"126","author":"Robbrecht","year":"2022","journal-title":"Br J Cancer"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae046\/57107541\/cvae046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/6\/581\/57425348\/cvae046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/6\/581\/57425348\/cvae046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T08:13:45Z","timestamp":1715069625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/6\/581\/7636615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":67,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,2]]},"published-print":{"date-parts":[[2024,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae046","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,4]]}}}